Enhancement of Dissolution Rate of Valdecoxib Using Solid Dispersions with Polyethylene Glycol 4000

References

• Asker, A. F., & Whitworth, C. W. (1975). Dissolution of acetyl salicylic acid from acetyl salicylic acid-polyethylene glycol 6000 coprecipitates. Pharmazie, 30, 530–531., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Barden, J., Edwards, J. E., McQuay, H. J., & Moore, R. A. (2003). Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review. BMC Anesthesiology (Online), 3, 1–8., [CROSSREF]
   PubMedGoogle Scholar
• Barzegar-Jalali, M., Maleki, N., Garjani, A., Khandar, A. A., Haji-Hosseinloo, M., Jabbari, R. C., & Dastmalchi, S. (2002). Enhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition technique. Drug Development and Industrial Pharmacy, 28, 681–686., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Betageri, G. V., & Makarla, K. R. (1995). Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. International Journal of Pharmaceutics, 126, 155–160., [CROSSREF]
   Web of Science ®Google Scholar
• Bolten, W. W. (1998). Scientific rationale for specific inhibition of cox-2. Journal of Rheumatology, 24, 2–7.
   Google Scholar
• Chiou, W. L., & Riegelman, S. (1971). Pharmaceutical applications of solid dispersions. Journal of Pharmaceutical Sciences, 60, 1281–1302., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Damian, F., Blaton, N., Naesens, L., Balzarini, J., Kinget, R., Augustinjns, P., & Mooter, G. V. (2000). Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. European Journal of Pharmaceutical Sciences, 10, 311–322., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Dannhardt, G., & Kiefer, W. (2001). Cyclooxygenase inhibitors—current status and future prospects. European Journal of Medical Chemistry, 36, 109–126., [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Desai, K. G. H., Kulkarni, A. R., & Aminabhavi, T. M. (2003). Solubility of rofecoxib in the presence of methanol, ethanol and sodium lauryl sulfate at (298.15, 303.15 and 308.15) K. Journal of Chemical and Engineering Data, 48, 942–945., [CROSSREF]
   Web of Science ®Google Scholar
• Fernandez, M., Rodriguez, I. C., Margarit, M. V., & Cerezo, A. (1992). Characterization of solid dispersion of piroxicam/polyethylene glycol 4000. International Journal of Pharmaceutics, 84, 197–202., [CROSSREF]
   Web of Science ®Google Scholar
• Ford, J. L. (1986). The current status of solid dispersions. Pharmaceutica Acta Helvetica, 61, 69–88.
   PubMedGoogle Scholar
• Goldberg, A. H., Gibaldi, M., & Kanig, J. L. (1965). Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures I-theoretical consideration and discussion of the literature. Journal of Pharmaceutical Sciences, 54, 1145–1148., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Goldberg, A. H., Gibaldi, M., & Kanig, J. L. (1966a). Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures II-experimental evaluation of a eutectic mixture: urea-acetaminophen system. Journal of Pharmaceutical Sciences, 55, 482–487.
   Web of Science ®Google Scholar
• Goldberg, A. H., Gibaldi, M., Kanig, J. L., & Mayersohn, M. (1966b). Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures IV-chloramphenicol-urea system. Journal of Pharmaceutical Sciences, 55, 581–583., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Higuchi, T., & Connors, K. (1965). Phase solubility techniques. Advances in Analytical Chemistry and Instrumentation, 4, 17–123.
   Google Scholar
• Lobenberg, R., & Amidon, G. L. (2000). Modern bioavailability, bioequivalence and biopharmaceutics classification system: new scientific approaches to international regulatory standards. European Journal of Pharmaceutics and Biopharmaceutics, 50, 3–12., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Leuner, C., & Dressman, J. (2000). Improving drug solubility for oral delivery using solid dispersions. European Journal of Pharmaceutical and Biopharmaceutics, 50, 47–60., [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Margarit, M. V., Rodriguez, I. C., & Cerezo, A. (1994). Physical characteristics and dissolution kinetics of solid dispersions of ketoprofen and polyethylene glycol 6000. International Journal of Pharmaceutics, 108, 101–107., [CROSSREF]
   Web of Science ®Google Scholar
• Najib, N. M., & Suleiman, M. S. (1989). Characterization of a diflunisal polyethylene glycol solid dispersion system. International Journal of Pharmaceutics, 51, 225–232., [CROSSREF]
   Web of Science ®Google Scholar
• Okonogi, S., Oguchi, T., Yonemochi, E., Puttipipatkhachorn, S., & Yamamoto, K. (1997a). Improved dissolution of ofloxacin via solid dispersion. International Journal of Pharmaceutics, 156, 175–180., [CROSSREF]
   Web of Science ®Google Scholar
• Okonogi, S., Yonemochi, E., Oguchi, T., Puttipipatkhachorn, S., & Yamamoto, K. (1997b). Enhanced dissolution of ursodeoxycholic acid from the solid dispersion. Drug Development and Industrial Pharmacy, 23, 1115–1121.
   Web of Science ®Google Scholar
• Ormrod, D., Wellington, K., & Wagstaff, A. J. (2002). Valdecoxib. Drugs, 62, 2059–2071., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rawat, S., & Jain, S. K. (2003). Rofecoxib-β-cyclodextrin inclusion complex for solubility enhancement. Pharmazie, 58, 639–641., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Serajuddin, A. T. M., Sheen, P. C., & Augustine, M. A. (1990). Improved dissolution of poorly water-soluble drug from solid dispersions in polyethylene: polysorbate 80 mixture. Journal of Pharmaceutical Sciences, 79, 463–464., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shin, S. C., & Kim, J. (2003). Physicochemical characterization of solid dispersion of furosemide with TPGS. International Journal of Pharmaceutics, 251, 79–84., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Shin, S. C., Oh, I. J., Lee, K. C., Lee, Y. B., & Koh, I. B. (1987). Dissolution enhancement of furosemide from ground mixtures with chitin or chitosan. Journal of Korean Pharmaceutical Sciences, 17, 175–181.
   Google Scholar
• Tang, L., Khan, S. U., & Muhammad, N. A. (2001). Evaluation and selection of bio-relevant dissolution media for a poorly water soluble new chemical entity. Pharmaceutical Development Technology, 6, 531–540., [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Yamashita, K., Nakate, T., Okimoto, K., Ohike, A., Tokunaga, Y., Ibuki, R., Higaki, K., & Kimura, T. (2003). Establishment of new preparation method for solid dispersion formulation of tacrolimus. International Journal of Pharmaceutics, 267, 79–91., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar